Jörg P Halter

24PUBLICATIONS
64CO-AUTHORS
PharmacogenomicsHaematological tumoursGene and molecular therapyCardiology (incl. cardiovascular diseases)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 24, 2026
Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

|Mar 04, 2026
Frequent NPM1 mutation, monoblastic/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study.

Alex Jenei, Béla Kajtár, Tamás László

|Jan 14, 2025
Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis.

Silke Heidenreich, Katharina Egger-Heidrich, Jörg P Halter

|Aug 13, 2024
Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation.

Marie Janscak, Anne Stelmes, Jana van den Berg

|Apr 21, 2023
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan.

Claire Seydoux, Chakradhara Rao Satyanarayana Uppugunduri, Michael Medinger

|Nov 03, 2022
Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH).

Silas Bänziger, Kimmo Weisshaar, Reetta Arokoski

Pageof 4

Frequent Collaborators

9 joint publications

Jakob R Passweg

6 joint publications

Michael Medinger

4 joint publications

Yves Chalandon

3 joint publications

Claire Seydoux